Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 14, 2025
Accession Number:
0001104659-25-103158
Submission Type:
POS AM
CIK:
0001621227
Company Name:
Adaptimmune Therapeutics PLC
File Number:
333-286639